IT services company, HCL Technologies, has landed a contract with independent clinical research organisation, Novotech.
Under the deal, HCL will implement Oracle’s Siebel Clinical Trial Management System (CTMS) during the next few months.
This is the first Australian life sciences customer win for the integrator. It was up against a few other providers that were considered for the deal, including eClinical solutions provider, Perceptive Informatics.
In a statement, HCL APAC executive vice-president, Virender Aggarwal, said it had more than 2000 staff servicing the A/NZ region and a broad set of global, multi-vendor capabilities to help Novotech become more agile.
The Siebel CTMS will support Novotech’s complete spectrum of clinical trial management services across Asia Pacific. The system will serve as a centralised repository to collect and track relevant information about clinical trials, and will manage them across different tiers including local, regional and global.
It will also offer an aggregate view of clinical trials undertaken by Novotech, provide up to date information to clients on project progress, supply timely and accurate reports, and dashboards to support tactical and strategic decision making.
The integrator will work with Novotech in phases, starting by assessing the company’s current proprietary clinical trial management system and providing a benchmark for where the system should be in terms of scalability and flexibility. Once the new system is implemented, HCL will also providing training for Novotech staff in using the new system.